Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men [3]




Fan Y., Laaksonen R., Janatuinen T., Vesalainen R., Nuutila P., Knuuti J., Lehtimäki T.

2001

Clinical Genetics

Clinical Genetics

60

4

319

321

3

0009-9163

DOIhttps://doi.org/10.1034/j.1399-0004.2001.600413.x

https://api.elsevier.com/content/abstract/scopus_id/0034749244




Last updated on 2024-26-11 at 18:37